Leadership

All

Our People

Leadership

Andrea F. Rabney

Founder and Chief Executive Officer

Maeve Conneighton

Senior Managing Director

Akhtar Samad, MD, PhD

Head of Strategic Consulting

David M. F. Pitts

Founder and President

John Garabo

Senior Managing Director

Laura M. Perry, CFA

Chief Operating Officer

Michelle Y. Pappanastos

Senior Managing Director

Managing Directors

Mary Coyle

Managing Director

Jason Finkelstein

Managing Director

Mariesa Kemble

Senior Media Relations Consultant

Samuel Martin

Managing Director

David Rosen

Managing Director, Media

Liza Sullivan

Managing Director

Deborah Elson

Managing Director

Melissa Forst

Managing Director

Nate LiaBraaten

Managing Director

Kimberly Minarovich

Managing Director

Dawn Schottlandt

Managing Director

Sarah Sutton, PhD

Managing Director

Julie Fallon

Managing Director

Stephanie Jacobson

Managing Director

Joshua R. Mansbach

Managing Director

Kevin Murphy

Managing Director

Brendan Strong

Managing Director

Kotaro Yoshida

Managing Director

Senior VPs & VPs

Michael Barron

Vice President

Paige Donnelly

Senior Vice President

Jay Liu

Assistant Vice President

Noor Pahlavi

Vice President

Claudia Styslinger

Senior Vice President

Brendan Burns

Vice President

Emily Huang

Vice President

Carrie McKim

Vice President

Patrick Pecorelli

Senior Vice President

Leo Vartorella

Senior Vice President

Matthew DeYoung

Vice President

Kaela Ilami

Assistant Vice President

Maghan Meyers

Senior Vice President

Valerie Schoeck

Assistant Vice President

Cameron Willis

Vice President

Associates

Ethan Andersen

Senior Associate

Sophie Hunt

Senior Associate

Shiv Madhok

Associate

Katie Plante

Senior Associate

Alissa Nakamoto

Senior Associate

Lily Overacker

Senior Associate

Ryan Porter

Senior Associate

Louise Xie

Senior Associate

Jacob Emanuel

Associate

Jack Magee

Associate

Andrew Vulis

Senior Associate

Creative & Digital

Adrienne Chen

Senior Art Director

Madeline Parker

Art Director

Luis Martinez

Graphic Designer

Marianne Schoucair

Senior Art Director

Joel Miller

Project Manager, Creative

Faith Simunyu

Senior Biomedical Illustrator

Operations

Janet Cushey

Operations Manager and Events

Adena Konetz

Operations Manager

Nikki Vukelj

Senior Operations Manager

All Staff

Ethan Andersen

Senior Associate

Brendan Burns

Vice President

Mary Coyle

Managing Director

Paige Donnelly

Senior Vice President

Melissa Forst

Managing Director

Emily Huang

Vice President

Mariesa Kemble

Senior Media Relations Consultant

Jay Liu

Assistant Vice President

Samuel Martin

Managing Director

Carrie McKim

Vice President

Joel Miller

Project Manager, Creative

Lily Overacker

Senior Associate

Michelle Y. Pappanastos

Senior Managing Director

Patrick Pecorelli

Senior Vice President

Katie Plante

Senior Associate

Andrea F. Rabney

Founder and Chief Executive Officer

Valerie Schoeck

Assistant Vice President

Dawn Schottlandt

Managing Director

Leo Vartorella

Senior Vice President

Kotaro Yoshida

Managing Director

Janet Cushey

Operations Manager and Events

Maeve Conneighton

Senior Managing Director

Jacob Emanuel

Associate

Julie Fallon

Managing Director

John Garabo

Senior Managing Director

Kaela Ilami

Assistant Vice President

Adena Konetz

Operations Manager

Shiv Madhok

Associate

Luis Martinez

Graphic Designer

Maghan Meyers

Senior Vice President

Kimberly Minarovich

Managing Director

Noor Pahlavi

Vice President

Laura M. Perry, CFA

Chief Operating Officer

David M. F. Pitts

Founder and President

David Rosen

Managing Director, Media

Claudia Styslinger

Senior Vice President

Faith Simunyu

Senior Biomedical Illustrator

Brendan Strong

Managing Director

Nikki Vukelj

Senior Operations Manager

Cameron Willis

Vice President

Michael Barron

Vice President

Adrienne Chen

Senior Art Director

Matthew DeYoung

Vice President

Deborah Elson

Managing Director

Jason Finkelstein

Managing Director

Sophie Hunt

Senior Associate

Stephanie Jacobson

Managing Director

Nate LiaBraaten

Managing Director

Jack Magee

Associate

Joshua R. Mansbach

Managing Director

Kevin Murphy

Managing Director

Alissa Nakamoto

Senior Associate

Madeline Parker

Art Director

Ryan Porter

Senior Associate

Akhtar Samad, MD, PhD

Head of Strategic Consulting

Marianne Schoucair

Senior Art Director

Liza Sullivan

Managing Director

Sarah Sutton, PhD

Managing Director

Andrew Vulis

Senior Associate

Louise Xie

Senior Associate

Andrea F. Rabney

Founder and Chief Executive Officer

David M. F. Pitts

Founder and President

Laura M. Perry, CFA

Chief Operating Officer

Maeve Conneighton

Senior Managing Director

John Garabo

Senior Managing Director

Michelle Y. Pappanastos

Senior Managing Director

Akhtar Samad, MD, PhD

Head of Strategic Consulting

Mary Coyle

Managing Director

Deborah Elson

Managing Director

Julie Fallon

Managing Director

Jason Finkelstein

Managing Director

Melissa Forst

Managing Director

Stephanie Jacobson

Managing Director

Mariesa Kemble

Senior Media Relations Consultant

Nate LiaBraaten

Managing Director

Joshua R. Mansbach

Managing Director

Samuel Martin

Managing Director

Kimberly Minarovich

Managing Director

Kevin Murphy

Managing Director

David Rosen

Managing Director, Media

Dawn Schottlandt

Managing Director

Sarah Sutton, PhD

Managing Director

Brendan Strong

Managing Director

Kotaro Yoshida

Managing Director

Liza Sullivan

Managing Director

Michael Barron

Vice President

Brendan Burns

Vice President

Matthew DeYoung

Vice President

Paige Donnelly

Senior Vice President

Emily Huang

Vice President

Kaela Ilami

Assistant Vice President

Jay Liu

Assistant Vice President

Carrie McKim

Vice President

Maghan Meyers

Senior Vice President

Patrick Pecorelli

Senior Vice President

Noor Pahlavi

Vice President

Valerie Schoeck

Assistant Vice President

Claudia Styslinger

Senior Vice President

Leo Vartorella

Senior Vice President

Cameron Willis

Vice President

Sophie Hunt

Senior Associate

Ethan Andersen

Senior Associate

Jacob Emanuel

Associate

Jack Magee

Associate

Shiv Madhok

Associate

Alissa Nakamoto

Senior Associate

Lily Overacker

Senior Associate

Katie Plante

Senior Associate

Ryan Porter

Senior Associate

Andrew Vulis

Senior Associate

Louise Xie

Senior Associate

Adrienne Chen

Senior Art Director

Luis Martinez

Graphic Designer

Joel Miller

Project Manager, Creative

Madeline Parker

Art Director

Marianne Schoucair

Senior Art Director

Faith Simunyu

Senior Biomedical Illustrator

Janet Cushey

Operations Manager and Events

Adena Konetz

Operations Manager

Nikki Vukelj

Senior Operations Manager

Ethan Andersen

Senior Associate

Michael Barron

Vice President

Brendan Burns

Vice President

Janet Cushey

Operations Manager and Events

Adrienne Chen

Senior Art Director

Mary Coyle

Managing Director

Maeve Conneighton

Senior Managing Director

Matthew DeYoung

Vice President

Paige Donnelly

Senior Vice President

Jacob Emanuel

Associate

Deborah Elson

Managing Director

Julie Fallon

Managing Director

Jason Finkelstein

Managing Director

Melissa Forst

Managing Director

John Garabo

Senior Managing Director

Sophie Hunt

Senior Associate

Emily Huang

Vice President

Kaela Ilami

Assistant Vice President

Stephanie Jacobson

Managing Director

Mariesa Kemble

Senior Media Relations Consultant

Adena Konetz

Operations Manager

Jay Liu

Assistant Vice President

Nate LiaBraaten

Managing Director

Shiv Madhok

Associate

Samuel Martin

Managing Director

Jack Magee

Associate

Joshua R. Mansbach

Managing Director

Luis Martinez

Graphic Designer

Maghan Meyers

Senior Vice President

Joel Miller

Project Manager, Creative

Kevin Murphy

Managing Director

Carrie McKim

Vice President

Kimberly Minarovich

Managing Director

Alissa Nakamoto

Senior Associate

Lily Overacker

Senior Associate

Michelle Y. Pappanastos

Senior Managing Director

Noor Pahlavi

Vice President

Madeline Parker

Art Director

Patrick Pecorelli

Senior Vice President

Laura M. Perry, CFA

Chief Operating Officer

Katie Plante

Senior Associate

Ryan Porter

Senior Associate

David M. F. Pitts

Founder and President

Andrea F. Rabney

Founder and Chief Executive Officer

David Rosen

Managing Director, Media

Akhtar Samad, MD, PhD

Head of Strategic Consulting

Valerie Schoeck

Assistant Vice President

Dawn Schottlandt

Managing Director

Marianne Schoucair

Senior Art Director

Faith Simunyu

Senior Biomedical Illustrator

Brendan Strong

Managing Director

Claudia Styslinger

Senior Vice President

Liza Sullivan

Managing Director

Sarah Sutton, PhD

Managing Director

Leo Vartorella

Senior Vice President

Nikki Vukelj

Senior Operations Manager

Andrew Vulis

Senior Associate

Cameron Willis

Vice President

Louise Xie

Senior Associate

Kotaro Yoshida

Managing Director

ANDREA F.
RABNEY

Founder and Chief Executive Officer

Ms. Rabney co-founded Argot Partners in 2007 as a life sciences-focused strategic communications consultancy to help companies of all sizes and stages articulate their science and its value to key stakeholders. She leverages her broad expertise and relationships within the financial industry to counsel clients on matters such as corporate positioning, mergers and acquisitions, financings and shareholder activism. During her tenure at Argot Partners, she has worked with more than 300 biopharmaceutical clients as a senior advisor at key inflection points across the corporate lifecycle.

 

Prior, Ms. Rabney served as Vice President, Corporate Communications at ImClone Systems (acquired by Eli Lilly and Company), where she was a member of the Management Committee and, for 13 years, led the company’s communications department. At ImClone, she was responsible for all communication initiatives, including the landmark $2 billion strategic partnership with Bristol-Myers Squibb, the regulatory failure and ultimate approval of the cancer treatment ERBITUX®, various government investigations, an exploration of strategic alternatives and a consent solicitation by investor Carl Icahn. Ms. Rabney began her career as a compliance analyst at Smith Barney Shearson Inc.

 

Ms. Rabney serves on the Board of Directors of the Red Door Community and as a member of its Executive Committee. She earned a J.D. from the Jacob D. Fuchsberg Law Center at Touro College and was admitted to practice law in New York State in 1993. She holds a Bachelor of Arts degree from Boston University.

Maeve Conneighton

Senior Managing Director

Maeve has over 10 years of experience in finance and investor relations. She joined Argot Partners in 2013, where she focuses on providing corporate communications counsel to biotechnology companies, specializing in investor relations program development and strategic communications. Maeve has worked with biotechnology companies across various sectors, ranging from oncology and specialty pharmaceuticals to synthetic biology and digital therapeutics. She has helped her clients navigate various communications issues, including data, regulatory decisions, commercial launch, financial guidance, litigation, and M&A and partnering communications. Maeve has also helped several companies raise private fundraising and crossover rounds, as well as guide them through the IPO process. Prior to joining Argot, Maeve was a compliance analyst at Highbridge Capital Management, where she worked on a variety of legal and compliance issues, including insider trading surveillance, regulatory reviews, and investment advisor disclosure requirements. She began her career as a paralegal at Seward & Kissel. Maeve earned her Bachelor of Arts degree from Barnard College of Columbia University with a major in Comparative Literature (English and French) and a minor in Art History.

Akhtar Samad MD, PhD

Head of Strategic Consulting

Prior to joining Argot, Dr. Samad established Symbios Partners to address an unmet need in the biotechnology advisory space by leveraging biomedical, drug development and financial analytical expertise to create a strategic advisory consultancy with a uniquely multidisciplinary skillset. From 2008-2016, he engaged client senior management teams on topics such as development of corporate strategy, clinical and business development strategy, competitive landscape analysis, crisis management and defining a differentiated investment thesis. Since 2016, he oversees these services to Argot’s biotechnology clients, as well as stock and shareholder analytics.


Prior to launching Symbios, Dr. Samad was a Managing Director at Bear Stearns where he directed the small/mid-cap biotechnology equity research team from 2000-2008. He is a former academic cancer and genomics researcher, and completed his postgraduate clinical training at Cornell, the National Cancer Institute and Harvard. He has been an invited moderator at the Annual Cancer Progress Conferences, and has conceived and moderated conferences on oncology, molecular diagnostics and genomics. He received his MD and PhD training at NYU Medical School.

David M. F. Pitts

Founder and President

Mr. Pitts co-founded Argot Partners with Andrea F. Rabney after their close collaboration at ImClone Systems (acquired by Eli Lilly and Company), where they navigated communications surrounding the landmark $2 billion strategic partnership with Bristol-Myers Squibb, the regulatory failure and ultimate approval of the cancer treatment ERBITUX®, various government investigations, an exploration of strategic alternatives and a consent solicitation by investor Carl Icahn. Mr. Pitts worked for ImClone as communications advisor and subsequently joined the company as a full-time corporate executive in 2004.

 

In 2007, Mr. Pitts and Ms. Rabney established Argot Partners as a life scienced-focused strategic communications consultancy to provide clients with a full suite of communications services to help communicate their narratives to key audiences at every stage of the biopharmaceutical lifecycle.

 

Mr. Pitts began his career in corporate communications at boutique special situations firm, Sard Verbinnen & Company, and later joined the Abernathy MacGregor Group, ultimately serving as a Senior Vice President. In these roles, he counseled multi-national clients through such matters as mergers and acquisitions, corporate crises, restructurings, proxy contests, initial public offerings, exchange listings and litigation.

 

Mr. Pitts earned his Bachelor of Arts degree in Asian Studies from Trinity College in Connecticut where he graduated with honors and thesis distinctions. He is fluent in French and proficient in Mandarin and Spanish.

John Garabo

Senior Managing Director

John brings 20 years of communications experience in the life science industry to Argot Partners, leveraging his in-house roles at large, mid-size and development-stage pharmaceutical companies and at a national not-for-profit healthcare organization. He began his healthcare career as a journalist covering infectious disease and mental health. At Argot, John provides clients with strategic corporate communications counsel.


Prior to joining Argot, John served as Director of Corporate Communications at Akebia Therapeutics, where he led communications and investor relations during the company’s merger with Keryx Biopharmaceuticals. Prior, John served as Associate Director of Corporate Communications at Ironwood Pharmaceuticals, where he led communications initiatives and product communications, including the launch of two FDA-approved products. Before Ironwood, John worked at Forest Laboratories, now AbbVie, where he formalized and integrated the company’s corporate communications function; in the healthcare division of a New York-based global public relations firm, as a Vice President; and for the Leukemia & Lymphoma Society, where he served as the National Director of Public Relations. John earned a B.S. in Mass Communication from Boston University.

Laura M.
Perry, CFA

Chief Operating Officer

Laura has over 20 years of experience providing investor relations and corporate communications counsel to biotechnology companies, specializing in investor relations program development and strategic communications. She has worked with a wide range of biotechnology companies throughout her career, from pre-IPO names to large-cap, revenue-generating companies. In addition to implementing effective investor relations outreach programs, she has helped her clients navigate a variety of complex communications issues, including M&A and partnering communications, data communications, financial guidance and crisis communications. Prior to joining Argot Partners in 2009, Laura served as an IR consultant for several small-cap biotechnology companies. Prior to that, she spent seven years at Stern Investor Relations, most recently as Vice President. Previously, she was a Director in the Biotechnology Group at The Carson Group, providing capital markets consulting and IR targeting services for emerging biotech companies. She began her career in the Corporate Finance Group at Montgomery Securities. She holds a B.A. in Science & Technology Studies from Cornell University and is a CFA® Charterholder.

Michelle Y. Pappanastos

Senior Managing Director

With over 18 years of experience, Michelle comes to Argot with a unique skill set having served in both investor relations and corporate development roles at publicly traded and private development stage life science companies. Specializing in the design and implementation of strategic corporate initiatives, investor relations program development, messaging, and communications writing, she is able to apply her professional insights to help emerging growth companies raise awareness and build beneficial relationships with investors, financial analysts, and the scientific and medical communities. Michelle also has extensive experience laying the groundwork for successful finance and stockholder initiatives including venture and follow-on financing rounds, IPOs, corporate milestone and data announcements, annual shareholder meetings, joint ventures and M&A transactions.


Prior to joining Argot Partners in 2012, Michelle served as Vice President, Corporate Development at Manhattan Pharmaceuticals, Inc. where she oversaw investor relations and business development, and worked alongside the corporate officers to develop and implement all of the major strategic corporate initiatives. Prior to that, she served at Javelin Pharmaceuticals, Inc. as Manager, Investor Relations and Corporate Affairs. Michelle holds a B.S. in Film and Television from New York University.

Mary Coyle

Managing Director

Mary is a healthcare communications veteran with two decades of experience innovating and executing strategic multichannel campaigns that increase brand awareness, spark dialogue, guard reputations, and drive business forward. She has worked with startups, publicly traded companies, government agencies and advocacy organizations. Mary has deep experience in data & regulatory milestones, product launches, corporate communications, issues management, internal communications & employee engagement, and advocacy relations. Her expertise spans several therapeutic areas, including oncology, cardiology, CNS, immunology, neuroscience, endocrinology, orthopedics and rare disease. She has worked at global marketing and communications agencies where she created innovative communications programs for Biogen, BMS, Eli Lilly, GE, Genomic Health, J&J, Lantheus, Krystal Biotech, Novartis, Pfizer, Sanofi and others.

Jason Finkelstein

Managing Director

Jason Finkelstein is a strategic financial and corporate communications leader with over 20 years of experience in the healthcare, technology, EV and financial services industries. His background and experience include both corporate and agency spanning all forms of stakeholder communications: investors, media, key opinion leaders, executive and financial leadership and Board of Directors. He has held various roles in the Pharmaceutical industry spanning from government contracting, clinical development and corporate finance.


He has a track record of successfully establishing Investor Relations for newly public companies and those preparing for IPOs.


Jason received his BA from Binghamton University and his M.B.A. in Finance from Baruch College’s Zicklin School of Business.

Mariesa Kemble

Senior Media Relations Consultant

Mariesa has over 25 years experience in securing award-winning global press coverage for biotechnology, environmental, medical diagnostics and medical device companies and the world’s pharmaceutical industry giants.


Some of these companies include: Abbott Laboratories, Abbott Nutrition, Abgenix, Advanced Ethanol Council, AGY Therapeutics, Align Technology, Allergan, Amgen, Anesiva, Applied Biosystems, Astellas, Bausch & Lomb, Baxter International, Bayer, Biogen, Boston Scientific, Calistoga Pharmaceuticals, Care.com, Cord Blood Registry, Covance, Covidien, CV Therapeutics, Cytori Therapeutics, Eisai, Elan Pharmaceuticals, Eli Lilly, Elsevier Publishing, FuelChoiceNow, Given Imaging, Galderma, Genentech, Genomic Health, Gladstone Institutes, Glaxo SmithKline, Haemonetics, Harvard Community Health Care, Healthline, H3 Biomedicine, Immune Response Corporation, Incyte, Intellia, Ipsen, Johnson & Johnson, Lundbeck, Medivation, Memory Pharmaceuticals, Medtronic, Metabolex, Microsoft Health, Myriant, Novartis, Oncology Therapeutics, Oncothyreon, Onyx Pharmacyclics, Qteros, Qualcomm Life, Roche Molecular Diagnostics, Sharecare, Syros Pharmaceuticals, Tetraphase, Together Rx, U.S. Surgical, Visudyne, Virologic, Xenoport and XPRIZE Foundation.


Mariesa consistently delivers high-profile press coverage in such media as Associated Press, Bloomberg, Reuters, Time, Newsweek/Daily Beast, US News & World Report, The Huffington Post, The New York Times, The Wall Street Journal, USA Today, Washington Post, Fortune, Forbes, Bloomberg Business Week, The Economist, Inc., Barron’s, Financial Times, Marketwatch, CNNMoney, TheStreet.com, Xconomy, Business Insider, The Deal, ABC World News Tonight with David Muir, Good Morning America, Nightline, CBS Evening News with Scott Pelley, CBS This Morning, NBC Nightly News with Lester Holt, TODAY, Fox News Channel, CNN, BBC, MSNBC, CNBC, Bloomberg TV, NPR, NOVA,The Doctors, Doctor Radio, Dr. Oz, The Doctors Channel, The Atlantic, The New Yorker, Scientific American, Discover, Popular Science, Wired, Fast Company, The Verge, VICE, Nature, Everyday Health, Health Day, MedPage Today, Medscape, WebMD, Parade, POLITICO, The Hill, MIT Technology Review, Futurism, TechCrunch, Mashable, CNET, InformationWeek, Endgadget, Medgadget, Gizmodo, The Saturday Evening Post, Prevention, Health, all the top women’s and men’s publications and countless trade outlets.
Mariesa has earned many awards for her work, including the prestigious Clarion award from Women in Communications, for publishing and editing a newsletter that she founded entitled, “MediaQuest, The Behind-The-Scenes Guide to the National Media”. MediaQuest has been used as a teaching tool in some of the top communications graduate programs, including the Columbia Graduate School of Journalism.


In addition, she has spearheaded national and international press coverage in public relations campaigns that have brought her repeated Silver Anvil awards for excellence in public relations.


Prior to consulting, Mariesa served as president of Atlantic Communications Group, a full-service media relations agency, Boston, MA, for eight years.

Samuel Martin

Managing Director

Sam brings to Argot over 17 years of experience in life sciences, having worked in investor relations, as well as in buy-side research, sell-side research and corporate finance. He specializes in development and execution of strategic investor relations programs for public and pre-IPO companies in the life sciences sector.


Sam joined Argot from The Ruth Group, an investor relations and public relations firm specializing in healthcare. Prior to The Ruth Group, Sam worked at LifeSci Advisors, a healthcare focused investor relations and equity research firm. Prior to joining LifeSci Advisors, he was a healthcare analyst at Clay Capital Management, where he was responsible for generating long/short portfolio positions and hedging strategies. Sam was also a healthcare analyst at Wachovia Securities (Wells Fargo), where he covered the Specialty Pharmaceutical sector. Prior to that, he worked in Financial Planning and Analysis at Merck.


Sam received his MBA in Finance from NYU Stern School of Business, and earned his BA in Economics from the University of California, Berkeley.

David Rosen

Managing Director, Media

David brings three decades of pharmaceutical and healthcare public relations experience to Argot Partners. He has significant product launch, crisis management, data promotion, patient education, internal communications and advocacy relations experience gained through both corporate and public relations agency roles. On the corporate side, he led US and Global communications for a number of therapeutic areas including Virology/HIV, Metabolics, Neuroscience and Rheumatology during his 10 years tenure at Bristol-Myers Squibb and DuPont Pharmaceuticals. On the agency side, David worked for several public relations agencies including Burson-Marsteller and Ogilvy Public Relations Worldwide. He has also been a communications lead for Meridian Health, a hospital system located in central New Jersey. Finally, as a result of his decades’ long interest in health care and his desire to constantly improve the lives of people in need, David is a certified Emergency Medical Technician (EMT) in the state of New Jersey. David holds a B.A. in Speech Communication from Ithaca College.

Liza Sullivan

Managing Director

Liza has nearly 20 years of agency experience with some of the leading firms in the country, working on a cross-spectrum of major clients in healthcare.


At Argot Partners Liza provides corporate communications strategy and leads thought leadership initiatives to enhance visibility for today’s leading biotech CEO’s and their management teams. Liza’s deep healthcare experience includes helping life sciences companies manage their reputations effectively when issues arise and implementing multi-media communications campaigns to promote news, corporate culture and key executives. Earlier in her career, she worked in the New York healthcare practice of a global PR agency designing and implementing campaigns for Phillips Healthcare, Pfizer’s drug CELEBREX, as well as for Hoffman La Roche’s oncology portfolio and Aventis’ flu and meningitis vaccines. In biotech, she has managed communications programs and social media presence for Apellis Pharmaceuticals, Apic Bio, Vigeo Therapeutics, Elicio, BiondVax, Raphael Pharma, and Ilex Oncology. Liza was a speaker at Deerfield Management’s inaugural CEO conference and is a board member of the New England Conservatory of Music. She holds a BA in Italian from Connecticut College.

Deborah Elson

Managing Director

Deborah Elson has 11+ years of global public relations, strategic communications and digital strategy experience in biopharma, science and medicine. Before joining Argot Partners in January 2021, Deborah served as a vice president on FleishmanHillard’s healthcare team. She counseled public and private biotech and pharmaceutical companies focused on CNS, rare diseases and gastrointestinal disorders, helping them navigate regulatory and corporate milestones and driving employee engagement, social media, website, thought leadership, corporate narrative, media strategy and issues management initiatives. During her tenure at the Society for Neuroscience, Deborah launched and oversaw a content website for the neuroscience field and led other content, marketing and communications initiatives. As a communications officer at the Sabin Vaccine Institute, she managed international media relations for neglected tropical disease drug and vaccine programs, placing news stories, conducting stakeholder relations and planning event communications. She began her career at a think tank and a crisis communications and reputation management agency.


Deborah earned her BA in international affairs, with a minor in art history, from The George Washington University, and her MPS in public relations and corporate communications from Georgetown University. She is an associate board member of Rethink Food, a nonprofit headquartered in New York City on a mission to reducing food insecurity.

Melissa Forst

Managing Director

Melissa joined Argot Partners in 2015 and brings over 10 years of broad healthcare and investor relations experience to the firm. In her role at Argot, she counsels both public and private biotech companies on the development, planning, and execution of their investor relations strategy, as well as strategic communications around data, regulatory updates, and other various corporate and financial disclosures. She previously served as a Senior Healthcare Research Project Manager at Guidepoint Global leading primary research projects for finance and corporate organizations across a variety of topics including therapeutics, medical devices, services, and healthcare IT. Melissa began her career as a Clinical Research Coordinator at St. Vincent’s Comprehensive Cancer Center managing numerous industry- and cooperative group-sponsored solid tumor clinical trials. She obtained her bachelor’s degree in Biology and Society and a minor in Nutrition and Health from Cornell University.

Nate LiaBraaten

Managing Director

Nate has over 15 years’ experience as a strategic finance specialist with a majority of that time spent working with publicly traded healthcare companies on both the buy-side and corporate-side. He has a robust understanding and appreciation for the nuances of planning and executing a successful investor relations program. Nate’s experience spans multiple therapeutic areas, stages of development and commercialization, size and structure of companies, and a myriad of investment vehicles and M&A partnership strategies. Nate joined Argot Partners in 2021 and is passionate about helping clients achieve their investor relations goals and optimize valuations.


Nate attended the University of Oregon where he played tight end for the Ducks football program, earning Team Captain honors, and graduated with a Bachelors in Business Administration, Bachelors in Psychology, minor in Economics, and MBA in Finance.

Kimberly Minarovich

Managing Director

Kimberly Minarovich brings to Argot over 25 years of experience in finance and investor relations. Kimberly joined the Argot Partners investor relations team in March 2016. Prior, she was Vice President at Burns McClellan where she led strategic investor relations programs for public life sciences companies as well as assisted companies in financings during pre-IPO stages through their IPOs. At Christensen International, she launched the company’s domestic healthcare practice and assisted numerous international companies with listings on the NYSE and NASDAQ exchanges. Ms. Minarovich began her IR career as Vice President, Investor Relations & Corporate Communications at Medicis Pharmaceutical.


Kimberly also spent nearly 15 years on Wall Street as a sell-side analyst at Goldman Sachs and Bear Stearns and as healthcare analyst on the buy-side at Bramwell Capital and Clay Finlay where she covered the global healthcare sector and was responsible for healthcare investments in domestic, European and emerging markets portfolios. She earned a Masters in Business Administration from Columbia Business School and a Bachelor of Arts degree from Lehigh University. She has also completed Level I of the CFA program. Kimberly speaks Polish and Italian and is pursuing coursework for a sommelier accreditation.

Dawn Schottlandt

Managing Director

Dawn Schottlandt brings to Argot 20 years of combined Investor Relations and Wall Street experience. Dawn joined Argot Partners in September 2020. Prior to joining Argot, she was the Vice President of Investor Relations and Corporate Communications at Chiasma, a publicly traded commercial-stage biopharma company focused on rare diseases. Previously, she served as Vice President of Investor Relations and Corporate Communications at ArQule, a publicly traded biopharma company focused oncology and rare diseases. She also served as Director of Investor Relations at Thermo Fisher Scientific, a leading life science tools company. Her first Investor Relations position was at Elan Corporation, an Irish based biopharma company focused on neurology. Prior to joining the healthcare sector, Dawn worked on Wall Street as both a sell side and buy side equity research analyst. Dawn holds a B.S from Boston College and is a CFA® Charterholder.

Sarah
Sutton, PhD

Managing Director

Sarah specializes in guiding corporate communications strategy for biotech companies. Her expertise includes corporate messaging and branding, media relations, issues preparedness and crisis management, thought leadership, and patient advocacy and disease awareness campaigns.


Sarah’s past and current clients include life sciences-focused venture capital firms and private and public biotech companies spanning all stages of clinical development. She has worked in a range of therapeutic areas, including cancer, rare disease, neuroscience, and the microbiome. She has guided her clients through many significant financial, clinical and regulatory milestones, and supported the launch of multiple new biotech companies.


Before joining Argot in 2021, Sarah led communications strategy for industry-leading biotech clients at the Glover Park Group and prior to that, at Ten Bridge Communications. She previously led writing projects for the fundraising team at the Broad Institute of MIT and Harvard. She began her career as a reporter at the Glens Falls (N.Y.) Post-Star. She holds a BA in History and Literary Arts from Brown University, and a PhD in History of Science from Brandeis University.

Julie Fallon

Managing Director

Julie is a strategic communications professional with more than 20 years of experience across investor relations, corporate communications, public relations, ESG reporting, and digital media. In her role as Managing Director at Argot Partners, she provides strategic investor relations counsel to clients to support fair market valuation, position companies for growth, and enhance brand reputation. She is passionate about working with clients who are innovating in healthcare and improving people’s lives.


Julie brings a breadth of communications experience, including IR strategy and program development, financial reporting, mergers and acquisitions, rebranding, and shareholder activism. Before joining Argot Partners, she was Senior Vice President, Investor Relations at MacDougall, a strategic communications agency, where she provided senior counsel in investor relations and ESG communications to clients in the life sciences industry. Prior to that, Julie was part of the global communications team at TJX, a Fortune 100 retailer, where she was responsible developing and implementing the corporate strategy for Environmental, Social, and Governance (ESG) communications and investor engagement. She also led the strategy and execution for corporate digital communications, managed corporate communications, and was a member of the crisis communications team. Prior to TJX, Julie was director of Investor Relations and Corporate Communications for Haemonetics, a global med tech company.

Stephanie Jacobson

Managing Director

Stephanie is an award-winning strategic communications leader with more than 25+ years of managing a range of challenges for leading companies across multiple industries, including pharmaceuticals and financial services.


Before joining Argot Partners in 2022, Stephanie served as Senior Vice President, Thought Leadership and Strategy at Green Room Communications, an integrated health care communications firm, where she counseled biotech, pharmaceutical and healthcare companies navigate regulatory and corporate milestones and drove thought leadership, corporate messaging, media strategy, employee engagement, social media, and issues management.


Stephanie has strong pharmaceutical experience, having led product communications for Janssen Pharmaceutical’s oncology portfolio and AstraZeneca’s cardiovascular portfolio. She has experience leading the internal and external communications support of NDA and sNDA filings and approvals as well as new product launches, data announcements and scientific presentations at major medical meetings. She also led global crisis communications around global supply issues and a U.S. Department of Justice investigation into a core clinical trial.


Stephanie is a graduate of Iowa State University and currently lives in West Chester, PA with her husband, son, and labradoodle Lucky.

Joshua R. Mansbach

Managing Director

Joshua R. Mansbach is an integrated communications strategist, storyteller, and content creator, with two decades of experience in healthcare communications. He has developed insights-driven, award-winning, brand and corporate programs that have catalyzed conversation, elevated awareness, and increased market share for global pharmaceutical companies, biotech innovators, research institutions, and advocacy organizations. Joshua’s background is in Science Strategy; developing compelling stories and innovative content that make company and product science memorable, and then crafting the strategies that engage stakeholders and spark dialogue about the company’s value proposition. Previously, Joshua led specialty Science Strategy practices for several global PR agencies, developing new capabilities and offerings across the spectrum of scientific communications, including storytelling, content strategies and asset creation, regulatory milestone strategies, issues/crisis management, and scientific/clinical data differentiation programs. As a strategic thought partner, he collaborates with clients to create actionable communications programs that demonstrate how brand and company science positively impacts public health and drives business growth.

Kevin Murphy

Managing Director

For the past 20 years at Lehman Brothers and Barclays, Kevin has covered some of the largest mutual funds in the United States as well as specialty healthcare funds in the Boston area. Working closely with bankers, analysts, syndicates, and corporate access, he has connected hundreds of private and public biopharma companies with qualified investors. He has developed deep relationships across the investment industry, particularly in the healthcare and biotech sectors. Kevin has consistently identified alpha-generating investments throughout his career, and in 2019 he achieved a return 23% above the S&P with alpha capture funds. He has helped management teams prepare detailed investor insights and has delivered timely and informative follow-up from investors. Prior to working at Lehman Brothers and Barclays, Kevin worked at Washington Research Group, a boutique firm focused on industries that are most affected by government regulatory, legislative, and budgetary policy changes. He is an avid American Red Cross platelet donor and a volunteer at the Great Boston Food Bank. He earned a BA in Economics at Boston College.

Brendan Strong

Managing Director

Brendan Strong has over 20 years of experience in investor relations, equity research and corporate finance with a deep background in healthcare. He enjoys helping companies craft and share their stories with the investment community. Brendan brings a wide-range of experience in investor relations and financial communications, including with transformative acquisitions, divestitures, cost-reduction initiatives, shareholder activism, say-on-pay, board refreshment and senior leadership change. During his time leading investor relations for Tenet Healthcare, the company was named a Most Honored Small-Cap Company by Institutional Investor and ranked No. 1 in the Best Investor Relations Program category among 202 small-cap healthcare companies. Brendan earned a B.S. in Finance from Rutgers University and an MBA from Harvard Business School.

Kotaro Yoshida

Managing Director

Kotaro is a healthcare subject matter expert and a communications specialist, partnering with some of the largest public pharma and biotech companies in the world as well as many private, pre-IPO healthcare firms. He has 15 years of relevant experience including extensive backgrounds in biomedical research, journalism, investor relations and data analytics.


He studied cancer immunology and immunotoxicology in graduate school, before becoming an investigative journalist for the business intelligence unit of the Financial Times where he covered US public and private healthcare markets. Later, Kotaro moved into healthcare IR, PR and crisis communications at FTI, developing communications strategies for companies like Patheon, Alexion and Intellia during IPOs, M&As, pivotal clinical data releases, and other major material events. Most recently, Kotaro led the healthcare arm of Global Intelligence, the data analytics division at Weber Shandwick, developing proprietary tools and methodologies to deliver data-driven insights to his clients for various branding and communications initiatives.


Kotaro received Bachelor’s degrees in Biology and Mathematics from Johns Hopkins University. He also received a Master’s degree in Biology from New York University, and a Master’s degree in Immunology from Duke University.

Michael Barron

Vice President

Michael joined Argot Partners in July 2019, where he served as a summer intern in 2018. He received his Bachelor of Arts degree in Media & Journalism and Psychology from the University of North Carolina at Chapel Hill.

Paige Donnelly

Senior Vice President

Paige brings 20+ years of corporate communications and public relations experience across a broad array of industries including Fortune 500 businesses. Before joining Argot Partners in August 2021, Paige provided communications consulting to small businesses and non-profit organizations focusing on social media, branding, public affairs, media relations and internal communications.


During her 11 years at Novozymes, a global biotech leader, she directed all aspects of communications for North America. She co-developed and managed an award-winning employee ambassador program to support the company’s public affairs efforts and developed a comprehensive public relations program to promote public adoption of biofuels. Her leadership drove significant increases in employee engagement, social media presence and influence, thought leadership, media coverage and issues management strategy and planning. She began her career in the corporate headquarters of McCaw Cellular Communications during its merger with AT&T and later IPO as AT&T Wireless Services.


Paige earned her BA in Communications/Public Relations at University of Washington and her MBA in management from Western International University. She lives in Raleigh, North Carolina.

Jay Liu

Assistant Vice President

Jay Liu joined Argot Partners in April 2022, where she focuses on providing counsel on corporate communications and investor relations strategy for public and private companies. Jay excels in high-stakes projects, advising clients in support of transformative events including SPAC transactions, leadership transitions, mergers and acquisitions, shareholder activism, take-private deals and bankruptcies. Her background includes deal advisory, special situations and crisis work spanning stakeholder groups including investors and analysts, media, employees, partners, regulators and legislators.


Jay has a track record of working closely with C-suite executives as they navigate challenging market dynamics. She brings significant experience implementing comprehensive media relations and public affairs campaigns in support of reputation management and value preservation. In her engagements, Jay has worked to establish companies’ investor relations functions and profile-raising post-IPO by driving stakeholder outreach, drafting and pitching thought leadership and op-eds, submitting award nominations and placing speaker opportunities.


In her previous role at Abernathy MacGregor, Jay advised on deals reaching up to 20B in valuation. Her other past clients include a Fortune 10 pharmaceutical company, an investment fund focused on the life sciences, and a FAANG company.


Jay received a B.S. in International Relations and Politics (IRP) and Social and Political History (SPH) and a B.A. in Chinese Studies from Carnegie Mellon University. She lives in New York.

Noor Pahlavi

Vice President

Noor joined Argot Partners in March 2022 as an AVP based in New York City. Previously, she worked at ICR Westwicke, an IPO advisory, capital markets, strategic communications and IR firm. There, she provided IR and consulting services to both public and private biotech and medical device companies. Prior to joining Westwicke, Noor worked as a Senior Associate at Stern IR, another healthcare-focused IR firm. She received an MBA from Columbia Business School and a BA in psychology from Georgetown University.

Claudia Styslinger

Senior Vice President

Claudia joined Argot Partners in September 2017, where she served as a summer intern in 2016. She works with a variety of privately-held and publicly-traded life sciences companies throughout various stages of funding and clinical development, including gene therapy, oncology, specialty pharma, synthetic biology, and orphan-disease companies. At Argot, she focuses on providing clients with corporate and strategic communications counsel, manages companies’ investor relations calendar for banking conferences, non-deal roadshows, KOL events, and medical meeting presentations, and analyzes companies’ investor base to guide targeted outreach to institutional investors. Claudia also aids companies in their fundraising process including private financings, IPOs, and follow-ons. She received her Bachelor of Arts degree in Foreign Affairs and French from the University of Virginia.

Brendan Burns

Vice President

Brendan works closely with privately held and publicly traded life science companies, development stage and commercial, to strategically plan and execute comprehensive investor relations and corporate communications initiatives, with a focus on private and public financings, data reporting, regulatory actions, change management, litigation and business development. He joined Argot Partners in May 2020 and earned his Bachelor of Science degree in Corporate Finance from Bentley University.

Emily Huang

Vice President

Emily joined Argot Partners in November 2021. Previously, she worked at State Street Corporation, one of the world’s largest asset servicers and asset managers, on the Investor Relations team. Prior to her role in Investor Relations, she completed State Street’s Finance Rotational Development Program, with rotations in Global Liquidity Management, Financial Planning and Analysis, Corporate Strategy, and Investor Relations. Emily graduated from Boston College with a B.S. in Finance and a B.A. in Economics.

Carrie McKim

Vice President

Carrie joined Argot Partners in 2021. Previously, she worked at Oxeon Partners, a healthcare-specific professional services firm specializing in recruiting C-suite executives, investing in businesses focused on unmet healthcare needs, and building de novo companies. While at Oxeon, Carrie worked with a variety of both privately-held and publicly-traded clients across the spectrum of tech-enabled healthcare services. She graduated from Duke University with a BA in Public Policy and a minor in Global Health.

Patrick Pecorelli

Senior Vice President

Patrick joins Argot Partners from Syneos Health where he served as VP in the Risk and Reputation Management group. He is an accomplished corporate communications professional with 20+ years’ experience in a broad range of industries including healthcare IT, medical devices, life sciences and B2B technology. He specializes in developing corporate narratives, building awareness, and driving transformations for both emerging companies and established businesses.


Prior to Syneos, Patrick successfully led his own communications consultancy where he developed and executed communications plans with a focus on PR, thought leadership, executive visibility, and social media. He has held in-house senior corporate marketing and communications roles at Wolters Kluwer Health, PerkinElmer, Excelitas Technologies, Luminus Devices and others.


Patrick earned a B.A. in English from Merrimack College in North Andover, MA.

Leo Vartorella

Senior Vice President

Leo joined Argot Partners in December 2020. He previously worked as a media strategist at FleishmanHillard and a reporter at Becker’s Healthcare. He earned a bachelor’s degree in journalism from the University of Wisconsin-Madison.

Matthew DeYoung

Vice President

Matthew joined Argot Partners in July 2019. Matthew received his Bachelor of Science Degree in Finance from the University of Vermont – Grossman School of Business and has previous professional experience at Pfizer Inc. and MeiraGTx.

Kaela Ilami

Assistant Vice President

Kaela Ilami joined Argot Partners in June 2021 as an AVP and is based in Austin, TX. Kaela was most recently a Team Leader at GLG (Gerson Lehrman Group) within their healthcare business, where her role was focused on client relationship management, project management and research within the life sciences space, while also managing a team of five client solution managers and associates through commercial success. Her research experience while at GLG spans across the entire healthcare value chain, including health plan optimization, investment decisions, therapeutic medical unmet needs, KOL meetings, and regulatory processes. Previously, she was an undergraduate researcher at the University of Texas at Austin, where she graduated with a degree in Microbiology and Infectious Diseases.

Maghan Meyers

Senior Vice President

Maghan joined Argot Partners in March 2018. Most recently, Maghan was an Account Coordinator at MacDougall Biomedical Communications. Maghan graduated from Boston College with a degree in Biology, and has professional experience in both investment banking with Deutsche Bank’s Healthcare Investment Banking Group, and in bench science at TetraLogic Pharmaceuticals.

Valerie Schoeck

Assistant Vice President

Valerie joined Argot Partners in July 2020, where she served as a summer intern in 2018 and 2019. She is a recent graduate of College of Charleston where she received her Bachelor of Arts in Communication.

Cameron Willis

Vice President

Cameron joined Argot Partners in May 2021. Previously, he worked as an investor relations consultant for The May-Dann Group, a healthcare services company focused on advancing telemedicine and rural medicine. Prior to May-Dann, he worked for The Ruth Group, an IR and PR agency with a healthcare focus, where he supported a range of healthcare clients, primarily across therapeutics, medical devices, and digital health. His experience covers both privately held and publicly traded healthcare companies as well as companies in all stages of development. Prior to The Ruth Group, Cameron worked for O&M Partners, a boutique IR consulting firm focused on the metals and mining sector, where he conducted outreach, organized roadshows, and hosted webinars. He received his B.A. in German from Columbia University.

Ethan Andersen

Senior Associate

Ethan joined Argot Partners in June 2020. In May 2020, he graduated from Cornell University’s College of Agricultural and Life Sciences and received his Bachelor of Science in Communication degree with a concentration in Business.

Sophie Hunt

Senior Associate

Sophie joined Argot Partners in August 2021. She is a recent graduate of Santa Clara University where she received her Bachelor of Arts in Communication with a minor in Business.

Shiv Madhok

Associate

Shiv joined Argot Partners in August 2022 as a Junior Associate based in New York City. He recently graduated from Boston University with a Bachelor of Arts degree in Biology.

Katie Plante

Senior Associate

Katie joined Argot Partners in March 2022. Previously, she was an analyst at Kendall IR, an investor relations firm that provides senior-level strategic and operational IR services to biotech companies. While at Kendall, Katie coordinated investor targeting for various clients. Katie has experience in working with executive management teams in both public and private biotech companies. She served as a Human Resources Intern at Intellia Therapeutics, gaining valuable experience in the public biotech environment. Katie also served as the Head Administrative Intern at Visterra Inc. and supported the company’s acquisition by Otsuka in 2018, including coordination of early integration efforts. She has a wide range of experience including investor targeting, general IR coordination, finance, and branding. She graduated from Providence College with a BS in Marketing and a minor in Finance.

Timothy Williams

Associate

Timothy joined Argot Partners in June 2021 as a Junior Associate. He is currently studying Business Management at Florida Atlantic University.

Jillian Augustine

Associate

Jillian graduated from Bucknell University in 2022, where she majored in Political Science and Creative Writing.

Alissa Nakamoto

Senior Associate

Alissa Nakamoto joined Argot Partners in September 2022, and she works with public and private life science companies across all stages of development and commercialization developing and executing investor relations programs. Prior to joining Argot Partners, Alissa was a senior analyst at Stern IR where she has gained IR experience across a wide range of biotechnology companies in various therapeutic areas including oncology, rare disease, ophthalmology, cardiovascular disease, and cell therapy. She graduated from Wesleyan University with a B.A. in Psychology and minor in Data Analysis and East Asian Studies.

Lily Overacker

Senior Associate

Lily joined Argot Partners in August 2021. She graduated in May of 2021 from Ithaca College, where she received a Bachelor of Science in Communication Management and Design with a concentration in Corporate Communication.

Ryan Porter

Senior Associate

Ryan Porter joined Argot Partners in June 2021. He has previous professional experience at Milestone Financial Planning and Annya, LLC. Ryan received his Bachelor of Science degree in Finance and a minor in Computer Information Systems from Bentley University.

Louise Xie

Senior Associate

Louise joined Argot Partners in August 2021, where she served as a summer intern in 2020. She received her Bachelor of Arts in Biology & Society and a minor in Asian American Studies from Cornell University.

Jacob Emanuel

Associate

Jacob joined Argot Partners in August 2022, where he served as a summer intern in 2021. He received his Bachelor of Arts degree in Communication and Media from the University of Michigan.

Jack Magee

Associate

Jack joined Argot Partners in August 2022. He graduated in May of 2022 from Cornell University, where he received a Bachelor of Science with distinction in Human Development with minors in Policy Analysis and Law.

Alex Piedrahita

Associate

Alex joined Argot Partners in June 2022. He received his Bachelor of Science in Biology from Cornell University.

Andrew Vulis

Senior Associate

Andrew joined Argot Partners in January 2022. He holds a dual bachelor’s degree in applied mathematics and statistics and Russian translation, with a minor in computer science, from Hunter College at the City University of New York.

Adrienne Chen

Senior Art Director

Adrienne has over 7 years of agency experience leading brands in creative storytelling, concepting, and design execution in print and digital mediums. She partners with teams to develop engaging, snackable content and effectively translates complex information into a visual language. Prior to joining Argot, Adrienne worked with clients at FleishmanHillard across various industries including: Johnson & Johnson, Janssen Pharmaceuticals, Chase, J.P. Morgan, Western Union, Nike, Krispy Kreme, and more. She has also led creative concept and design for communication materials for FDA-approval and refreshed brand identities for life science and healthcare clients. She started her career at Ogilvy in Washington, DC, where she supported digital strategy for national campaigns for the National Institutes of Health. Adrienne graduated magna cum laude from Skidmore College where she received a B.A. in psychology and minored in studio art.

Madeline Parker

Art Director

Madeline joined Argot Partners as a senior designer in late 2021. Since 2018, she has worked closely with biotechnology and life science companies on wide array of design projects. She specializes in social media graphics, data visualization, website design, brand work and collateral, presentation design and scientific poster creation. With a strong passion for both the sciences and the arts, Madeline enjoys finding new and compelling ways to expand upon a brand story, informed by a shared understanding of the science, culture and drive of the individuals who make up the team she is working with.


Prior to joining Argot, Madeline worked as a freelance designer and illustrator, and various roles at Ten Bridge Communications, Seres Therapeutics, the University of Wisconsin-Madison and the Institute for Discovery in Madison. During her time at the University of Wisconsin-Madison and the Institute for Discovery, she worked as a lab manager for the Visual Reasoning Lab, devoting her attention to studying “inferred mappings” for how visual features, such as color, will map onto concepts in information visualization, as well as the Virtual Environments Group (formerly the Living Environments Laboratory), which explores various academic projects using virtual reality. While at the Visual Reasoning Lab, Madeline worked on two publications on inferred mappings, as well as a conference presentation she gave at the annual Vision Sciences Society meeting.


Madeline graduated with honors from Wheaton College, where she received a Bachelor of Arts degree in both neuroscience and studio art. She was awarded membership to the Tri Beta Honorary Biological Society and the Psi Chi National Psychology Honorary Society.

Luis Martinez

Graphic Designer

Luis is a graphic designer with over ten years of experience who Joined Argot Partners in November 2021. He specializes in rebranding, presentation design, marketing collateral, and photography/videography.


Previous clients include Opko, BioReference Laboratories, Prudential Financial, The Blackstone Group, Janssen/Johnson & Johnson, Douglas Elliman, Ferring Pharmaceuticals, Conduit Global, The Red Panda Network, McCann Health, Moderna, among others. Luis earned a Bachelor of Science Degree in Digital Arts & Design from Full Sail University.

Marianne Schoucair

Senior Art Director

Marianne joined Argot Partners as a senior art director in July 2021. She has over 10 years of design experience, serving as lead creative on a variety of campaigns and projects in both in-house and agency roles, as well as managing creative teams on a day-to-day basis. An award winning designer, Marianne has extensive experience in print, web, UX, and branding. Before joining Argot, Marianne worked at Fidelity Investments, Thinkargus and Tenbridge Communications, and freelanced for clients in the health, non-profit and education fields.


Marianne received her Bachelor’s degree in graphic design at the Massachusetts College of Art and Design, and her Master’s degree in graphic design at Boston University, both with honors.

Joel Miller

Project Manager, Creative

Joel has worked in agency creative departments for the past decade, first as a copywriter developing a range of traditional and digital content for many Fortune 100 brands, and now as a project manager overseeing the full lifecycle of various creative projects.


Joel was previously the Creative Project Manager at PrizeLogic, where he led creative production for promotional websites and loyalty programs for clients including Johnson & Johnson, Lowe’s and Disney.

Faith Simunyu

Senior Biomedical Illustrator

Faith Simunyu joined Argot Partners as a board-certified Senior Biomedical Illustrator in June 2021. She combines deep scientific knowledge and artistic principles to create 2D and 3D illustrations – rendering science accurately, beautifully and comprehensibly across audiences.


Prior to joining Argot, Faith successfully started and expanded the biomedical illustration offering at Ten Bridge Communications where she partnered with teammates to create effective science visuals for clients in the biotech industry. Projects included developing new and branded imagery to communicate key scientific concepts such as mechanisms of action that were featured on websites, with the goal of giving clients ownable visual identities specific to their story. These scientific illustrations were further expanded to meet client-specific communication needs on social media platforms, scientific papers, publications and PowerPoint Presentations.


Faith received her bachelor’s degree in Chemistry from Denison University and went on to obtain her Master of Science in Biomedical Visualization from the University of Illinois at Chicago.

Janet Cushey

Operations Manager and Events

Janet joined Argot Partners in December 2014. She previously worked as an Event Manager for Shoptalk, a leading retail conference. Prior, Janet was an instructor in South Korea where she acted as a rehabilitator for North Korean refugees. She has also assisted in microbiology research at Case Western Reserve University in Cleveland, Ohio. Janet obtained her bachelor’s degree in East Asian Studies at Wesleyan University and speaks both Korean and French.